SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Director/PDMR Shareholding

7 Nov 2013 12:59

RNS Number : 4796S
Carillion PLC
07 November 2013
 

Carillion plc

(the 'Company')

Half Year Dividend for the Six Months Ended 30 June 2013

Dividend Reinvestment Plan

Pursuant to a Dividend Reinvestment Plan offered to shareholders of Carillion plc whose names appeared on the register of members on 6 September 2013, the following PDMRs of the Company acquired on 6 November 2013 the share interests shown at a price of £3.0587 per share: 

 

PDMR

Carillion Shares Acquired

(Ord shares of 50p each)

Total Interest Following

this Notification*

Richard Howson

Group Chief Executive

1,493

85,341

Richard Adam

Group Finance Director

354

158,238

Simon Webb

MD Al Futtaim Carillion JV

66

14,690

*Each interest less than 0.04% of the issued share capital. 

Tim George

Deputy Company Secretary

Carillion plc

7 November 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAAFXESPDFFF
Date   Source Headline
1st Mar 20177:00 amRNSFinal Results
2nd Feb 20174:25 pmRNSHolding(s) in Company
2nd Feb 20177:00 amRNSCarillion Extends Openreach Framework Agreement
30th Jan 20173:42 pmRNSCarillion refinances maturing debt facilities
23rd Jan 20173:25 pmRNSHolding(s) in Company
20th Jan 201712:46 pmRNSHolding(s) in Company
19th Jan 20179:20 amRNSDirectorate Change
4th Jan 20177:00 amRNSCarillion JV awarded £160 million contract
20th Dec 20169:29 amRNSBlock listing Interim Review
16th Dec 201612:37 pmRNSHolding(s) in Company
16th Dec 20168:09 amRNSHolding(s) in Company
15th Dec 20168:15 amRNSHolding(s) in Company
7th Dec 20164:46 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSCarillion selected as the preferred bidder
7th Dec 20167:00 amRNSFull year trading update
6th Dec 20165:36 pmRNSHolding(s) in Company
5th Dec 20164:06 pmRNSHolding(s) in Company
2nd Dec 20163:46 pmRNSHolding(s) in Company
2nd Dec 20162:45 pmRNSHolding(s) in Company
29th Nov 201611:03 amRNSHolding(s) in Company
4th Nov 201610:49 amRNSDirector/PDMR Shareholding
1st Nov 20161:30 pmRNSCarillion Joint Ventures awarded contract by MoD
25th Oct 20167:42 amRNSHolding(s) in Company
21st Oct 20169:37 amRNSHolding(s) in Company
6th Oct 20167:58 amRNSHolding(s) in Company
4th Oct 20167:00 amRNSCarillion wins £350m contract for Nationwide
15th Sep 20167:44 amRNSHolding(s) in Company
5th Sep 20167:00 amRNSCarillion selected by Centrica for contract
24th Aug 20167:05 amRNSHalf-year Report
24th Aug 20167:00 amRNSDirectorate Change
15th Aug 20161:56 pmRNSHolding(s) in Company
29th Jul 20169:16 amRNSHolding(s) in Company
26th Jul 20161:16 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSCarillion subsidiary in joint venture
26th Jul 20167:00 amRNSCarillion joint venture achieves financial close
22nd Jul 20162:59 pmRNSHolding(s) in Company
20th Jul 20166:01 pmRNSHolding(s) in Company
18th Jul 20164:43 pmRNSHolding(s) in Company
15th Jul 20169:35 amRNSHolding(s) in Company
14th Jul 20163:58 pmRNSHolding(s) in Company
14th Jul 20162:30 pmRNSHolding(s) in Company
14th Jul 20167:41 amRNSHolding(s) in Company
13th Jul 20162:44 pmRNSHolding(s) in Company
13th Jul 20169:51 amRNSHolding(s) in Company
12th Jul 20163:25 pmRNSHolding(s) in Company
8th Jul 20168:01 amRNSHolding(s) in Company
6th Jul 20167:00 amRNSHALF-YEAR TRADING UPDATE
6th Jul 20167:00 amRNSCarillion awarded contracts worth up to £600m
29th Jun 20167:54 amRNSHolding(s) in Company
29th Jun 20167:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.